A new report in the journal “Nature Reviews Clinical Oncology suggests” that we could be inching closer to using aspirin as part of clinical guidelines in cancer prevention. Aspirin has also been shown to reduce the risk of colorectal cancer and colorectal polyps. Although taking aspirin daily has some promising benefits, it can also raise the risk of gastrointestinal bleeding. The results of six trials stated that the group taking daily aspirin had approximately a 20% reduction in cancer incidence between three and five years, and a 30% reduction after more than five years.
No comments:
Post a Comment